Back to Search
Start Over
Development of novel backbones for the treatment of peripheral T-cell lymphoma (PTCL): The pralatrexate/romidepsin doublet
- Source :
- Journal of Clinical Oncology. 34:2552-2552
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 2552Background: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of lymphomas in which only 20-25% of patients experience long-term survival with CHOP chemotherapy. Recently several drugs...
- Subjects :
- Cancer Research
Chemotherapy
Pathology
medicine.medical_specialty
Heterogeneous group
business.industry
medicine.medical_treatment
Pralatrexate
CHOP
medicine.disease
Peripheral T-cell lymphoma
Lymphoma
Romidepsin
03 medical and health sciences
0302 clinical medicine
Oncology
immune system diseases
hemic and lymphatic diseases
030220 oncology & carcinogenesis
medicine
Cancer research
business
030215 immunology
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........d57405397e37305304bf9e8d24a75e4d
- Full Text :
- https://doi.org/10.1200/jco.2016.34.15_suppl.2552